Introduction
============

Members of the genus *Campylobacter* are Gram-negative epsilonproteobacteria highly adapted to vertebrate hosts. Most *Campylobacter* species are pathogens in a wide range of livestock species \[[@B18]\] and also have extensive reservoirs in wildlife \[[@B3]\]. In particular, the species *Campylobacter* (*C.*) *fetus* is an important veterinary pathogen that can also infect humans. This species is currently divided into *C. fetus* subspecies (subsp.) *fetus* (*Cff*) and *C. fetus* subsp. *venerealis* (*Cfv*). A phenotypic variant designated as *C. fetus* subsp. *venerealis* biovar *intermedius* (*Cfvi*) has also been described \[[@B24]\].

*Cff* causes abortion mainly in sheep \[[@B6]\] and to a lesser extent in cattle. In humans, this is an opportunistic microorganism that mainly infects immune-compromised patients \[[@B12],[@B21]\]. *Cfv* is the causative agent of bovine genital campylobacteriosis (BGC), an infectious venereal disease which leads to reproductive problems such as infertility, lowered pregnancy rates, and abortion \[[@B4]\]. This subspecies is thought to be a cattle-specific pathogen and has been isolated from bull preputial cavities, cow vaginal mucus, and the organs of aborted fetuses \[[@B16],[@B18]\]. Although *Cfvi* shows characteristics similar to those of *Cfv*, it is unclear whether it can occur only in the genital tract or both the genital and intestinal tracts \[[@B5],[@B6]\]. Campylobacteriosis is a matter of concern for the cattle industry worldwide as this disease causes significant economic losses \[[@B2],[@B15]\]. Infected animals are subjected to trade restrictions and it is therefore mandatory to report outbreaks to the World Organization for Animal Health (OIE).

In order to collect epidemiological information and other clinically relevant data about *C. fetus* infection, adequate diagnostic methods are required. Bacteriological analyses, such as culture isolation and biochemical tests, are useful for evaluating different kinds of samples even with low bacterial counts (*e.g.*, preputial washings from bulls). Although these methods are well standardized and extensively used, they are laborious and time-consuming, thus making them disadvantageous when processing large-scale samples or delivering a fast diagnosis. Molecular methods using polymerase chain reaction (PCR) have become a good alternative for obtaining rapid and highly specific bacterial diagnoses \[[@B8],[@B11],[@B27]\]. There are relatively few assays described for *C. fetus* \[[@B1],[@B10],[@B23],[@B25]\]. The most widely used is a multiplex PCR technique that detects *C. fetus* and differentiates between its subspecies \[[@B7]\]. This assay amplifies a 764-bp fragment that is specific for *C. fetus*, and an additional 142-bp fragment that appears in *Cfv* but not *Cff* \[[@B7]\]. However, the amplicon used as a marker for *Cfv* has been reported to produce results that contradict those of other assays \[[@B7],[@B19]\]. New markers for *Cfv* have been suggested \[[@B1],[@B23]\], but have not been extensively applied.

In the present study, we developed a multiplex PCR assay to amplify a *C. fetus*-specific 764-bp sequence (*C. fetus* marker) and a 233-bp sequence that is only present in *Cfv* (*Cfv* marker). The latter marker was recently identified by whole-sequence genome comparisons between both subspecies \[[@B13]\]. This multiplex PCR assay allowed straightforward detection of the species *C. fetus* and *Cfv* subspecies, and was standardized using cultured strains. The assay was also successfully used to evaluate DNA extracted directly from the abomasal liquid contents of aborted bovine fetuses without any pre-enrichment step.

Materials and Methods
=====================

Multiplex PCR design
--------------------

The multiplex PCR assay included two sets of commercial primers synthesized by Integrated DNA Technologies (USA). These primer sets were previously described in the literature but had never been used simultaneously ([Table 1](#T1){ref-type="table"}). The primer set MG3F/MG4F amplifies a 764-bp region of the *cstA* gene, which is a widely used genetic marker for *C. fetus* \[[@B7]\]. The primer set nC1165g4F/nC1165g4R amplifies a 233-bp amplicon of the *virB11* gene that is present in *Cfv* but not in *Cff* \[[@B13]\]. Multiplex PCR using these two primer sets would accordingly produce only the 764-bp amplicon for *Cff*, and yield both the 764-bp and 233-bp amplicons in the case of *Cfv*.

Bacterial strains
-----------------

Standardization of the multiplex PCR assay was performed with cultured Uruguayan, Australian, and Argentinian strains of *Cff*, *Cfv*, and *Cfvi*, provided from reference laboratories of Division of Veterinary Laboratories (DILAVE), Uruguay and National Institute of Agricultural Technology (INTA), Argentina, that are routinely used as controls for diagnostic procedures in Uruguay. Abomasal liquid from an Uruguayan aborted fetus that had been stored at -20℃ since 1998 was included as an additional control. A bacterial strain characterized as *Cff* had been previously isolated from this liquid in DILAVE. The multiplex-PCR assay was also performed with 10 Uruguayan samples collected from the field during 2010. These samples were directly obtained from the abomasal contents of bovine aborted fetuses ([Table 2](#T2){ref-type="table"}). *C. jejuni*, *C. sputorum* subsp. *bubulus* (*Csb*), *C. coli*, *C. hyointestinalis*, and *Escherichia* (*E.*) *coli* were used as negative controls (INTA, Argentina) ([Table 2](#T2){ref-type="table"}); these are Uruguayan and Argentinian strains that are routinely used as negative controls for diagnostic laboratories.

Sample testing with standard bacteriological methods
----------------------------------------------------

Control and field strains were previously typed using standard bacteriological methods for *Campylobacter fetus* subespecies differentiation \[[@B9]\] in order to test the multiplex-PCR assay specificity. Bacterial samples were grown in heart brain infusion agar (Sigma-Aldrich, USA) and *Campylobacter* selective supplement (Thermo Fisher Scientific, USA) as selective medium under microaerophillic conditions for 48 h at 37℃. The presumptive *Campylobacter* colonies were grown in Brucella broth (Sigma-Aldrich, USA) with 1% glycine (Sigma-Aldrich, USA) and in Brucella broth with NaCl and cysteine (Sigma-Aldrich, USA) to detect H~2~S production with lead acetate paper (Sigma-Aldrich, USA).

Typing samples by multiplex PCR
-------------------------------

DNA was extracted from 500 µL of control strain colonies (1 × 10^8^ CFU/mL) resuspended and diluted 10-fold in PBS (pH 7.4) using a QIAamp DNA Mini Kit (Qiagen, Germany) according to the manufacturer\'s protocol. The DNA purification protocol was the same for the ten field samples although 1,000 µL of liquid abomasal content from the aborted fetuses was used. Nanodrop 1000 (Thermo Scientific, USA) was used to assess the extracted DNA purity, measured as the ratio of absorbance at 260 and 280 nm (A~260/280~).

The multiplex PCR reaction was first optimized with different concentrations of specific components, including MgCl~2~, Taq, and dNTPs, as well as various ratios of both primer sets. The best results were obtained when 1 µL of DNA was used in a 20-µL reaction containing 0.5 mM of each dNTP (Thermo Scientific, USA), 2 µL of 1× reaction buffer (Thermo Scientific, USA), 2.5 mM MgCl~2~ (Thermo Scientific, USA), 0.625 µM MG3F/MG4R primer set, 0.375 µM nC1165g4F/nC1165g4R primer set, and 1.5 U Taq DNA polymerase (Thermo Scientific, USA). A Corbett PCR Thermal Cycler (Qiagen, Germany) was used for amplification. The following cycling conditions were used: an initial denaturation for 3 min at 95℃ followed by 35 cycles of denaturation for 30 sec at 94℃, annealing for 30 sec at 53℃, and extension for 1 min at 72℃. Amplicons were separated in 1.0% agarose gels and stained with ethidium bromide.

Sequence analysis
-----------------

Amplicons from one of the field samples (6600) were purified using a QIAquick PCR Purification Kit (Qiagen, Germany) and sequenced using an ABI Prism 377 automated sequencer (Applied Biosystems, USA). The resulting sequences were submitted to the GenBank database, and the Basic Local Alignment Search Tool (National Center for Biotechnology Information, USA) was used to measure their similarity with publicly available DNA sequences.

Sensitivity evaluation of the multiplex PCR assay
-------------------------------------------------

To measure assay sensitivity, two different approaches were used. First, five serial 2-fold dilutions of abomasal liquid from field samples known to be positive were prepared and DNA was isolated. DNA quantification was then performed using a Nanodrop 2000 (Thermo Scientific, USA). Dilutions containing 40, 20, 10, 5, and 2.5 ng of DNA/µL were thus made. One µL of purified DNA from each dilution was used for the PCR reactions.

Second, known dilutions (10^1^, 10^3^, 10^5^, and 10^7^ CFU/mL) of *Cff* and *Cfv* were mixed with 1 mL of bull semen extracted from commercial insemination syringes \[[@B20]\] or macerated cattle lungs (INTA, Argentina). Both of these materials were originally negative for *Campylobacter*. DNA was extracted from each mixture using a QIAamp DNA Mini Kit (Qiagen, Germany) following the manufacturer\'s protocol for tissues. Multiplex PCR assay was performed using 1 µL of each DNA sample.

Results
=======

Testing the control strains using standard bacteriological methods
------------------------------------------------------------------

*C. fetus* control strains were tested using standard bacteriological methods. *Cff*063, *Cff*A28, *Cff*C1N3, *Cff*584, and *Cff*710 grew in 1% glycine and produced H~2~S. Accordingly, they were classified as *Cff*. On the other hand, *Cfv*3598, *Cfv*D78, *Cfv*608, and *Cfv*371 did not grow in 1% glycine and were unable to generate H~2~S. This resulted in their designation as *Cfv*. *Cfvi*470 did not grow in 1% glycine but produced H~2~S; this microorganism was thus classified as *Cfvi* ([Table 2](#T2){ref-type="table"}).

Testing the field strains using standard bacteriological methods
----------------------------------------------------------------

None of the field strains were able to grow in 1% glycine or produce H~2~S. Therefore, all were classified as *Cfv* ([Table 2](#T2){ref-type="table"}).

Multiplex PCR standardization
-----------------------------

The multiplex PCR assay was standardized using genomic DNA extracted from previously cultured control strains. No PCR products were recovered with template DNA from non-*C. fetus* bacterial species that were used as negative controls ([Table 2](#T2){ref-type="table"}). PCR reactions with template DNA from *Cfv* and *Cfvi* yielded 764-bp and 233-bp amplicons. When using template DNA from *Cff*, only the species-specific 764-bp amplicon was produced ([Table 2](#T2){ref-type="table"} and [Fig. 1](#F1){ref-type="fig"}). Non-specific amplification was not observed at any time.

Field strain typing using the multiplex PCR assay
-------------------------------------------------

Once standardized with the control strains, the multiplex PCR assay was conducted to analyze DNA extracted from the 10 field samples without any pre-enrichment steps. Initial identification of the strains present in the field samples (*Cfv*) was confirmed by the production of two amplicons with the expected sizes ([Table 2](#T2){ref-type="table"} and [Fig. 2](#F2){ref-type="fig"}).

Sequence analysis
-----------------

Specificity of the multiplex PCR, assessed by comparison with phenotypic data, was further confirmed by amplicon sequencing. The sequence of the *C. fetus* amplicon (GenBank accession No. JF893945) was 100% identical to the *cstA* gene in the reference *Cff* 82-40 genome (GenBank accession No. NC_008599) and with three other published sequences of this gene (GenBank accession Nos. AY158813, AY158814, and NZ_ACLG01001165). The *Cfv* amplicon (GenBank accession No. JF901335) was 100% identical to the *virB11* gene in the *Cfv* Azul-94 genome (GenBank accession No. NZ_ACLG01001023).

Assay sensitivity
-----------------

Sensitivity of the multiplex PCR was measured using decreasing dilutions of DNA obtained from the field samples. Assay sensitivity essentially remained unchanged when using 40 to 5 ng/µL of template DNA from the abomasal liquid. No PCR products were produced when using 2.5 ng/µL of the template DNA. All DNA dilutions had an A~260/280~ ratio between 1.8 and 2.0, indicating relatively high purity. Results of this study indicated that the detection limit for DNA from abomasal liquid is between 5 and 2.5 ng/µL.

Sensitivity was further analyzed by examining semen and lung samples spiked with known concentrations of bacteria. PCR amplification was observed when using 1 µL of sample from semen or lung inoculated with 10^3^, 10^5^, and 10^7^ CFU/mL but not 10^1^ CFU/mL. This finding indicates that the detection limit for bacteria in a sample is around 10^3^ CFU regardless of the source material (semen or lung).

Discussion
==========

The multiplex PCR assay described herein is able to identify the species *C. fetus* and distinguish between its subspecies in a single step. The assay design is based on PCR amplification of a species-specific marker to identify *C. fetus* and an exclusive *Cfv* sequence that discriminates between subspecies. The species-specific marker has been widely used for the molecular diagnosis of *C. fetus* and no cross-reaction has been reported with other bacterial species \[[@B7],[@B23]\]. This marker was used in the only multiplex PCR assay previously described in the literature for identifying species and subspecies of *C. fetus*. However, the subspecies marker originally included in this method showed cross-reactivity with *Cff* and other *Campylobacter* species \[[@B7],[@B19]\]. Although other markers for subspecies differentiation have been proposed \[[@B1],[@B23]\], the most significant progress in this field has come from whole genome comparison between subspecies; this comparison identified a pathogenicity island present in *Cfv* but not *Cff* which contains many genes that could be potentially used as subspecies-specific markers for *Cfv* \[[@B13]\] . In the current investigation, we selected a 233-bp sequence present in the *Cfv* pathogenicity island to perform subspecies differentiation with our multiplex PCR assay. Under optimal conditions, this exclusive *Cfv* sequence was amplified with the same efficiency as the *C. fetus* species-specific marker in the PCR reaction.

The assay was standardized using cultured control strains that allowed the rapid, straightforward detection of *C. fetus* and subspecies discrimination based on the presence or absence of specific amplicons. *Cff* was identified by the presence of only one amplicon (764 bp) while *Cfv* resulted in two amplicons (764 bp and 233 bp) of distinct sizes. This multiplex PCR assay produced the same amplicon pattern for *Cfvi* and the other *Cfv* strains we tested. However, Moolhuijzen et al. \[[@B13]\] analyzed one strain of *Cfvi* using the same primer set and found that this subspecies had the same profile as *Cff*. To date, a specific set of primers that can distinguish *Cfvi* from other *C. fetus* strains has not been validated, suggesting that this subspecies represents a heterogeneous subset within *C. fetus* \[[@B13]\]. A more definitive genetic characterization of this biovar should be performed, particularly as it seems to be relatively common in some adult cattle populations \[[@B16]\].

Application of the assay for analyzing cultured samples can be used as a complement to biochemical methods since our PCR-based technique reduces the diagnosis time by avoiding the need for additional tests to identify subspecies. It is noteworthy that this multiplex PCR assay can be used for samples taken directly from aborted fetuses. To the best of our knowledge, only one recent report exists in which PCR methods were used for analyzing DNA directly extracted from abomasal liquid to detect *C. fetus* \[[@B22]\]. However, our report is the first that describes subspecies discrimination using abomasal liquid as starting material.

The methodology we developed represents a good tool for obtaining epidemiological information, like frequency and etiology, pertaining to bovine abortions. A main advantage of this assay is that the whole process (DNA extraction, multiplex PCR, and gel electrophoresis) allows the detection and discrimination of *C. fetus* subspecies in approximately 5 h in contrast to traditional bacteriological methods that require about 1 week. Nucleotide sequences of the amplicons obtained from aborted fetuses by multiplex PCR were identical to those found in the GenBank database, so these markers seemed to be conserved and appropriate for diagnostic purposes. The assay also produced negative results for *C. jejuni*, *Csb*, *C. coli*, *C. hyointestinalis*, and *E. coli*, demonstrating high specificity even with closely related species. These findings demonstrated that the assay was correctly standardized and proved to be sensitive when using as little as 5 ng of DNA extracted from the abomasal content of aborted bovine fetuses. Adequate sensitivity was also achieved using tissues and body fluids inoculated with at least 10^3^ CFU. Hence, it is feasible to perform standardization using other kinds of non-cultured samples, like preputial washings or vaginal mucus, with low bacterial counts.

It is well known that *Cfv* is responsible for chronic infections leading to continuous reproduction problems although the association of this subspecies with abortion is not clear. We reviewed publications \[[@B1],[@B14],[@B17],[@B26]\] in which aborted fetuses were used as samples and found that 41 cases of abortion (76%) were due to *Cfv* while 13 (24%) were caused by *Cff*. Accordingly, *Cfv* caused the vast majority of abortions in cattle compared to *Cff* that is widely recognized for its association with sheep abortion \[[@B6]\]. The 10 field samples analyzed in the current study were obtained in 2010 and all were found to exclusively contain *Cfv*. These results are indicative of *Cfv* being the most relevant subspecies involved in abortion events in Uruguayan cattle.

Although some variability has been reported for traditional bacteriological methods (growth in 1% glycine and H~2~S production) used to differentiate *C. fetus* subspecies, these techniques are extensively regarded as the gold standard. When comparing data from these traditional methodologies, our multiplex PCR assay was able to correctly identify subspecies in all cases. This finding, together with the easy and quick performance of our PCR-based technique, supports the potential use of our method not only as a routine diagnostic test for BGC but also as a high throughput method for obtaining relevant epidemiological data.

![Multiplex PCR results for *C. fetus* subsp. *fetus* (*Cff*), *C. fetus* subsp. *venerealis* (*Cfv*), *C. fetus* subsp. *venerealis* biovar *intermedius* (*Cfvi*), and the negative control strains. Lane 1: negative control (no template), Lane 2: 200-bp molecular weight ladder, Lane 3: *Cff*063, Lane 4: *Cff*A28, Lane 5: *Cfv*3598, Lane 6: *Cfv*D78, Lane 7: *Cfvi*470, Lane 8: *C. sputorum* subsp. *bubulus*, Lane 9: *C. jejuni*, Lane 10: *C. hyointestinalis*, Lane 11: *C. Coli*, and Lane 12: *E. coli*.](jvs-13-371-g001){#F1}

![Multiplex PCR results of the four field samples. Lane 1: negative control (no template), Lane 2: 200-bp molecular weight ladder, Lane 3: *Cfv* positive control, Lane 4: 6600, Lane 5: 3726, Lane 6: 3837, and Lane 7: 2733. The four field samples were identified as *Cfv*.](jvs-13-371-g002){#F2}

###### 

Primers used for the multiplex PCR assay

![](jvs-13-371-i001)

^\*^The MG3F and MG4R primer names and sequences were previously reported by Hum et al. \[[@B7]\]. ^†^The nC1165g4F and nC1165g4R primer names and sequences were previously reported by Moolhuijzen et al. \[[@B13]\]. *C. fetus*: *Campylobacter fetus*, *Cfv*: *C. fetus* subsp. *venerealis*.

###### 

Phenotyping and multiplex PCR genotyping results for all samples analyzed in this study

![](jvs-13-371-i002)

^\*^Hum et al. \[[@B7]\]; ^†^Moolhuijzen et al. \[[@B13]\], +: positive, -: negative, NA: not assayed, *Cff*: *C. fetus* subsp. *fetus*, *Cfv*: *C. fetus* subsp. *venerealis*, *Csb*: *C. sputorum* subsp. *bubulus*, *Cfvi*: *C. fetus* subsp. *venerealis* biovar *intermedius*.
